| | APRIL 20224 One of the silver linings of the pandemic has been the catalytic effect it caused in the pharmaceutical and life sciences segment. Despite the havoc it created in the healthcare domain with the excessive number of patients against the lack of resources, the pharma & life sciences industry has fast-forwarded its future by many years. As immediately as the pandemic began, the industry was under immense pressure and in a predicament where the only option was a success--developing the COVID-19 vaccine.The industry heavily leveraged technologies, and it paid off. By the end of 2020, Pfizer and BioNTech achieved the first authorization in the world for a vaccine to combat COVID-19. It was not just a pharmaceutical breakthrough but a fresh hope for humanity--for hundreds of billions of people around the world who almost stopped living their lives. India's first COVID-19 vaccine - COVAXIN, developed by Bharat Biotech, was also soon approved. Smart technologies, like Artificial Intelligence (AI), Machine Learning (ML), and Natural Language Processing (NLP), became vital tools in the process. Today, around 94 percent of the country's adult population has received at least one dose, and over 80 percent of the adult population has been covered by both doses. India has also commenced giving the COVID-19 vaccine to children aged between 12 and 14 years. For a country with a population of more than 130 crores, it's a remarkable achievement. The government deserves credit as much as pharmaceutical companies do. It's India making a strong statement to the world with its responsible and swift actions.Do let us know your thoughts.Sujith VasudevanManaging Editoreditor@ceoinsightsindia.comThe New Face of PharmaVol 03 · Issue 12 · April 2022 Publisher Alok Chaturvedi Managing Editor Sujith Vasudevan EditorialKeerthana Kantharaj Sthitaprajnya PanigrahiTanuja Akkannavar Deepawali DuttaAveek Pal Chaudhuri Ananth V Lakshmi G Group Art DirectorAshok KumarNoida Rohit Raghubanshi Garima Anandadvertise@ceoinsightsindia.comEditorial queries editor@ceoinsightsindia.comTo subscribeVisit www.ceoinsightsindia.com/subscribe/ or send emailto subscription@ceoinsightsindia.comCover price is Rs.150 per issue.Editor Alok ChaturvediPrinted and Published By Alok Chaturvedi on behalf of InfoConnect Web Technolo-gies India Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Copyright © 2022 InfoConnect Web Technologies India Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher. Design Suanya Chakraborty Souvik Acharya Rajesh R.BVP - Sales & Marketing Amrit SinghCirculation Manager Magendran PerumalEditorial
< Page 3 | Page 5 >